Your browser doesn't support javascript.
loading
Expression of PD-L1 in ovarian cancer and its synergistic antitumor effect with PARP inhibitor.
Xue, Chunyan; Xu, Yun; Ye, Wenfeng; Xie, Quanqin; Gao, Hongyan; Xu, Bin; Zhang, Dachuan; Jiang, Jingting.
Afiliación
  • Xue C; Department of Tumor Biological Treatment, Soochow University, Jiangsu, Changzhou 213003, China; Department of Obstetrics and Gynecology, Soochow University, Jiangsu, Changzhou 213003, China.
  • Xu Y; Department of Tumor Biological Treatment, Soochow University, Jiangsu, Changzhou 213003, China; Department of Obstetrics and Gynecology, Soochow University, Jiangsu, Changzhou 213003, China.
  • Ye W; Department of Tumor Biological Treatment, Soochow University, Jiangsu, Changzhou 213003, China; Department of Obstetrics and Gynecology, Soochow University, Jiangsu, Changzhou 213003, China.
  • Xie Q; Department of Tumor Biological Treatment, Soochow University, Jiangsu, Changzhou 213003, China; Jiangsu Engineering Research Center for Tumor Immunotherapy, Soochow University, Jiangsu, Changzhou 213003, China; Institute of Cell Therapy, Soochow University, Jiangsu, Changzhou 213003, China.
  • Gao H; Department of Tumor Biological Treatment, Soochow University, Jiangsu, Changzhou 213003, China; Department of Obstetrics and Gynecology, Soochow University, Jiangsu, Changzhou 213003, China.
  • Xu B; Department of Tumor Biological Treatment, Soochow University, Jiangsu, Changzhou 213003, China; Jiangsu Engineering Research Center for Tumor Immunotherapy, Soochow University, Jiangsu, Changzhou 213003, China; Institute of Cell Therapy, Soochow University, Jiangsu, Changzhou 213003, China.
  • Zhang D; Department of Tumor Biological Treatment, Soochow University, Jiangsu, Changzhou 213003, China; Pathology Department, The Third Affiliated Hospital of Soochow University, Soochow University, Jiangsu, Changzhou 213003, China.
  • Jiang J; Department of Tumor Biological Treatment, Soochow University, Jiangsu, Changzhou 213003, China; Jiangsu Engineering Research Center for Tumor Immunotherapy, Soochow University, Jiangsu, Changzhou 213003, China; Institute of Cell Therapy, Soochow University, Jiangsu, Changzhou 213003, China. Electron
Gynecol Oncol ; 157(1): 222-233, 2020 04.
Article en En | MEDLINE | ID: mdl-31987601
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antígeno B7-H1 / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antígeno B7-H1 / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2020 Tipo del documento: Article País de afiliación: China